We decided to further develop the first humanized, floxed ABCA7 knock-in mouse crossbred with the amyloidogenic model APPPS1-21 to investigate how changes in this ABC transporter might affect Aβ metabolism and contribute to neuroinflammation in AD. This evidence concerns the gene ABCG2 and Alzheimer disease.